Patent ID: 6605295
Filing Date: 2003-08-12
Classification: A61K,A61P,Y10S

Abstract:
A stable ophthalmic composition for topical administration to eye tissue comprising:0.001 to 0.15 weight percent of diclofenac or a salt thereof; 0.01 to 0.5 weight percent of ofloxacin or the hydrochloride thereof; 0.001 to 0.02 weight percent of sodium disulphite; 0 to 5 weight percent of povidone; 0 to 2 weight percent of polysorbate; 0 to 5 weight percent of sodium chloride; 0 to 10 weight percent of sorbitol; 0 to 1.0 weight percent of benzalkonium chloride; 0 to 0.002 weight percent of sodium edetate; an alkali hydroxide or acid in an amount effect to adjust a pH value of the composition to a value greater than about 7; and water.